Summary by Moomoo AI
China Traditional Chinese Medicine Holdings Co., Ltd. ("Trad Chi Med") held its annual shareholders' meeting on June 14, 2024, during which all proposed resolutions were approved by shareholder vote. These resolutions included the approval of the financial statements, board of directors' report, and independent auditor's report for the fiscal year ending December 31, 2023, as well as the re-election of multiple directors and authorization of the board of directors to determine director remuneration. In addition, Ernst & Young was re-appointed as the company's auditor and authorized to determine its remuneration. Directors in attendance at the shareholders' meeting included Executive Director Mr. Chen Yinglong, Non-Executive Director Mr. Cheng Xueren, as well as Independent Non-Executive Directors Mr. Xie Rong, Mr. Yu Zishan, Mr. Qin Ling and Mr. Li Weidong. Hong Kong Central Clearing and Settlement System acted as the vote scrutineer responsible for vote counting. As of the meeting date, the total number of issued shares of the company was 5,035,801,852 shares.